Search for content, post, videos

Novo Nordisk launches 100% renewable power target for suppliers


Novo Nordisk has announced a target to ensure all its direct suppliers supply the company based on 100% renewable power by 2030.

Novo Nordisk will work with all existing and new suppliers to meet the target. The plan will be presented in connection with Climate Week NYC.

Circular for Zero

This commitment is the next step in Novo Nordisk’s ‘Circular for Zero’ environmental strategy, which launched in April 2019 and set an ultimate ambition for the company to have zero environmental impact.


Read more: Pharma industry confronts growing problem of pharmaceutical waste

The majority of Novo Nordisk’s total carbon emissions originate in its supply chain, making this commitment with suppliers on renewable power integral to achieving Novo Nordisk’s environmental strategy. In achieving this target, Novo Nordisk would therefore be eliminating at least 300,000 tons of greenhouse gases from its supply chain. Novo Nordisk has already committed to achieve zero CO2 emissions from the company’s own global operations and transport by 2030 and, in 2020, achieved the target of using 100% renewable power across its global production.

“Our ambition of achieving zero environmental impact is a cornerstone of our aspiration to be a truly sustainable business,” says CEO Lars Fruergaard Jørgensen. “Achieving it requires that we look beyond our own organisation and collaborate across multiple sectors with suppliers to accelerate the transition to renewable power. We hope that others across the corporate sector will also benefit from these actions. I would like to pay tribute to the commitment of our suppliers, on whom this new ambition depends.”

Sourcing renewable power

To reach the target, Novo Nordisk will work alongside suppliers, sharing with them what it has learned on embedding renewable power through its operations. Suppliers’ ability to meet the 100% renewable power target will be continually evaluated.

Read more: Lundbeck, Novo Nordisk and AstraZeneca on ‘A list’ for climate change

SCHOTT, a producer of specialty glass and supplier of pharma packaging to Novo Nordisk, has committed to becoming carbon neutral by 2030. Sourcing renewable power will be one pillar of their company strategy.

“Our transition to carbon neutrality is fuelled by close exchange and collaboration with valued customers. As one example, Novo Nordisk has shared valuable insights from their own experiences of sourcing renewable power. As part of our Zero Carbon strategy, we are taking action to reduce the environmental impact of our operations,” says SCHOTT CEO Frank Heinricht.

Image caption: Final visual inspection of the glass containers by the human eye before shipping to customers. Copyright: SCHOTT AG